Regulation of immune cell responses by semaphorins and their receptors

Cellular and Molecular Immunology

Volumn 7, Issue 2, 2010, Pages 83-88

  Takamatsu, Hyota ^a,b   Okuno, Tatsusada ^a,b   Kumanogoh, Atsushi ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Autoimmune diseases; Immune cell trafficking; Immune regulation; Semaphorin; Tumorigenesis

Indexed keywords

CD72 ANTIGEN; NEUROPILIN 1; PLEXIN A1; PLEXIN A4; PLEXIN B1; PROTEIN TIM 2; RECEPTOR; SEMAPHORIN; SEMAPHORIN 3A; SEMAPHORIN 4A; SEMAPHORIN 4D; SEMAPHORIN 6C; SEMAPHORIN 6D; SEMAPHORIN 7A; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 1;

B LYMPHOCYTE ACTIVATION; CELL INTERACTION; CELL MIGRATION; CYTOKINE PRODUCTION; DENDRITIC CELL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; LEUKOCYTE MIGRATION; MACROPHAGE; MONOCYTE; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE ACTIVATION; TH2 CELL; THYMUS;

ANIMALS; CELL COMMUNICATION; CELL MOVEMENT; HUMANS; LYMPHOID TISSUE; RECEPTORS, CELL SURFACE; SEMAPHORINS;

EID: 77749283694     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2009.111     Document Type: Review

References (92)

1. Steinman L. Elaborate interactions between the immune and nervous systems. Nat Immunol 2004; 5: 575-581.
2. Tole S, Mukovozov IM, Huang YW, Magalhaes MA, Yan M, Crow MR et al. The axonal repellent, Slit2, inhibits directional migration of circulating neutrophils. J Leukoc Biol 2009; 86: 1403-1415.
3. Prasad A, Qamri Z, Wu J, Ganju RK. Slit-2/Robo-1 modulates the CXCL12/CXCR4-induced chemotaxis of T cells. J Leukoc Biol 2007; 82: 465-476.
4. Wu JY, Feng L, Park HT, Havlioglu N, Wen L, Tang H et al. The neuronal repellent Slit inhibits leukocyte chemotaxis induced by chemotactic factors. Nature 2001; 410: 948-952.
5. Kitamura T, Kabuyama Y, Kamataki A, Homma MK, Kobayashi H, Aota S et al. Enhancement of lymphocyte migration and cytokine production by ephrinB1 system in rheumatoid arthritis. Am J Physiol Cell Physiol 2008; 294: C189-C196.
6. Hjorthaug HS, Aasheim HC. Ephrin-A1 stimulates migration of CD81CCR71 T lymphocytes. Eur J Immunol 2007; 37: 2326-2336.
7. Aasheim HC, Delabie J, Finne EF. Ephrin-A1 binding to CD41 T lymphocytes stimulates migration and induces tyrosine phosphorylation of PYK2. Blood 2005; 105: 2869-2876.
8. Sharfe N, Freywald A, Toro A, Dadi H, Roifman C. Ephrin stimulation modulates T cell chemotaxis. Eur J Immunol 2002; 32: 3745-3755.
9. Kolodkin AL, Matthes DJ, Goodman CS. The semaphorin genes encode a family of transmembrane and secreted growth cone guidance molecules. Cell 1993; 75: 1389-1399.
10. Unified nomenclature for the semaphorins/collapsins. Semaphorin Nomenclature Committee. Cell 1999; 97: 551-552.
11. Zhou Y, Gunput RA, Pasterkamp RJ. Semaphorin signaling: progress made and promises ahead. Trends Biochem Sci 2008; 33: 161-170.
12. Toyofuku T, Yoshida J, Sugimoto T, Yamamoto M, Makino N, Takamatsu H et al. Repulsive and attractive semaphorins cooperate to direct the navigation of cardiac neural crest cells. Dev Biol 2008; 321: 251-262.
13. Toyofuku T, Kikutani H. Semaphorin signaling during cardiac development. Adv Exp Med Biol 2007; 600: 109-117.
14. Toyofuku T, Yabuki M, Kamei J, Kamei M, Makino N, Kumanogoh A et al. Semaphorin-4A, an activator for T-cell-mediated immunity, suppresses angiogenesis via Plexin-D1. EMBO J 2007; 26: 1373-1384.
15. Serini G, Valdembri D, Zanivan S, Morterra G, Burkhardt C, Caccavari F et al. Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function. Nature 2003; 424: 391-397.
16. Gu C, Yoshida Y, Livet J, Reimert DV, Mann F, Merte J et al. Semaphorin 3E and plexin-D1 control vascular pattern independently of neuropilins. Science 2005; 307: 265-268.
17. Capparuccia L, Tamagnone L. Semaphorin signaling in cancer cells and in cells of the tumor microenvironment-two sides of a coin. J Cell Sci 2009; 122: 1723-1736.
18. Neufeld G, Kessler O. The semaphorins: versatile regulators of tumour progression and tumour angiogenesis. Nat Rev Cancer 2008; 8: 632-645.
19. Giordano S, Corso S, Conrotto P, Artigiani S, Gilestro G, Barberis D et al. The semaphorin 4D receptor controls invasive growth by coupling with Met. Nat Cell Biol 2002; 4: 720-724.
20. Takegahara N, Takamatsu H, Toyofuku T, Tsujimura T, Okuno T, Yukawa K et al. Plexin-A1 and its interaction with DAP12 in immune responses and bone homeostasis. Nat Cell Biol 2006; 8: 615-622.
21. Suzuki K, Kumanogoh A, Kikutani H. Semaphorins and their receptors in immune cell interactions. Nat Immunol 2008; 9: 17-23.
22. Kikutani H, Kumanogoh A. Semaphorins in interactions between T cells and antigenpresenting cells. Nat Rev Immunol 2003; 3: 159-167.
23. Pasterkamp RJ, Kolodkin AL. Semaphorin junction: making tracks toward neural connectivity. Curr Opin Neurobiol 2003; 13: 79-89.
24. Tamagnone L, Artigiani S, Chen H, He Z, Ming GI, Song H et al. Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell 1999; 99: 71-80.
25. Takahashi T, Fournier A, Nakamura F, Wang LH, Murakami Y, Kalb RG et al. Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors. Cell 1999; 99: 59-69.
26. Winberg ML, Noordermeer JN, Tamagnone L, Comoglio PM, Spriggs MK, Tessier-Lavigne M et al. Plexin A is a neuronal semaphorin receptor that controls axon guidance. Cell 1998; 95: 903-916.
27. Suzuki K, Okuno T, Yamamoto M, Pasterkamp RJ, Takegahara N, Takamatsu H et al. Semaphorin 7A initiates T-cell-mediated inflammatory responses through alpha1beta1 integrin. Nature 2007; 446: 680-684.
28. Pasterkamp RJ, Peschon JJ, Spriggs MK, Kolodkin AL. Semaphorin 7A promotes axon outgrowth through integrins and MAPKs. Nature 2003; 424: 398-405.
29. Kumanogoh A, Watanabe C, Lee I, Wang X, Shi W, ArakiH et al. Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling. Immunity 2000; 13: 621-631.
30. Kumanogoh A, Marukawa S, Suzuki K, Takegahara N, Watanabe C, Ch'ng E et al. Class IV semaphorin Sema4A enhances T-cell activation and interacts with Tim-2. Nature 2002; 419: 629-633.
31. Puschel AW. GTPases in semaphorin signaling. Adv Exp Med Biol 2007; 600: 12-23.
32. Kruger RP, Aurandt J, Guan KL. Semaphorins command cells to move. Nat Rev Mol Cell Biol 2005; 6: 789-800.
33. Toyofuku T, Yoshida J, Sugimoto T, Zhang H, Kumanogoh A, Hori M et al. FARP2 triggers signals for Sema3A-mediated axonal repulsion. Nat Neurosci 2005; 8: 1712-1719.
34. Oinuma I, Ishikawa Y, Katoh H, Negishi M. The Semaphorin 4D receptor Plexin-B1 is a GTPase activating protein for R-Ras. Science 2004; 305: 862-865.
35. Barberis D, Casazza A, Sordella R, Corso S, Artigiani S, Settleman J et al. p190 Rho-GTPase activating protein associates with plexins and it is required for semaphorin signalling. J Cell Sci 2005; 118: 4689-4700.
36. Swiercz JM, Kuner R, Behrens J, Offermanns S. Plexin-B1 directly interacts with PDZRhoGEF/ LARG to regulate RhoA and growth cone morphology. Neuron 2002; 35: 51-63.
37. Perrot V, Vazquez-Prado J, Gutkind JS. Plexin B regulates Rho through the guanine nucleotide exchange factors leukemia-associated Rho GEF (LARG) and PDZ-RhoGEF. J Biol Chem 2002; 277: 43115-43120.
38. Aurandt J, Vikis HG, Gutkind JS, Ahn N, Guan KL. The semaphorin receptor plexin-B1 signals through a direct interaction with the Rho-specific nucleotide exchange factor, LARG. Proc Natl Acad Sci USA 2002; 99: 12085-12090.
39. Uchida Y, Ohshima T, Yamashita N, Ogawara M, Sasaki Y, Nakamura F et al. Semaphorin3A signaling mediated by Fyn-dependent tyrosine phosphorylation of collapsin response mediator protein 2 at tyrosine 32. J Biol Chem 2009; 284: 27393-27401.
40. Sasaki Y, Cheng C, Uchida Y, Nakajima O, Ohshima T, Yagi T et al. Fyn and Cdk5 mediate semaphorin-3A signaling, which is involved in regulation of dendrite orientation in cerebral cortex. Neuron 2002; 35: 907-920.
41. Mitsui N, Inatome R, Takahashi S, Goshima Y, Yamamura H, Yanagi S. Involvement of Fes/Fps tyrosine kinase in semaphorin3A signaling. EMBO J 2002; 21: 3274-3285.
42. Toyofuku T, Zhang H, Kumanogoh A, Takegahara N, Suto F, Kamei J et al. Dual roles of Sema6D in cardiac morphogenesis through region-specific association of its receptor, Plexin-A1, with off-track and vascular endothelial growth factor receptor type 2. Genes Dev 2004; 18: 435-447.
43. Swiercz JM, Worzfeld T, Offermanns S. ErbB-2 and met reciprocally regulate cellular signaling via plexin-B1. J Biol Chem 2008; 283: 1893-1901.
44. Delaire S, Elhabazi A, Bensussan A, Boumsell L. CD100 is a leukocyte semaphorin. Cell Mol Life Sci 1998; 54: 1265-1276.
45. Bougeret C, Mansur IG, Dastot H, Schmid M, Mahouy G, Bensussan A et al. Increased surface expression of a newly identified 150-kDa dimer early after human T lymphocyte activation. J Immunol 1992; 148: 318-323.
46. Kumanogoh A, Suzuki K, Ch'ng E, Watanabe C, Marukawa S, Takegahara N et al. Requirement for the lymphocyte semaphorin, CD100, in the induction of antigenspecific T cells and the maturation of dendritic cells. J Immunol 2002; 169: 1175-1181.
47. Shi W, Kumanogoh A, Watanabe C, Uchida J, Wang X, Yasui T et al. The class IV semaphorin CD100 plays nonredundant roles in the immune system: defective B and T cell activation in CD100-deficient mice. Immunity 2000; 13: 633-642.
48. Huber AB, Kolodkin AL, Ginty DD, Cloutier JF. Signaling at the growth cone: ligandreceptor complexes and the control of axon growth and guidance. Annu Rev Neurosci 2003; 26: 509-563.
49. Parnes JR, Pan C. CD72, a negative regulator of B-cell responsiveness. Immunol Rev 2000; 176: 75-85.
50. Pan C, Baumgarth N, Parnes JR. CD72-deficient mice reveal nonredundant roles of CD72 in B cell development and activation. Immunity 1999; 11: 495-506.
51. Okuno T, Nakatsuji Y, Moriya M, Takamatsu H, Nojima S, Takegahara N et al. Involvement of Sema4D-Plexin-B1 interactions in the central nervous system for pathogenesis of experimental autoimmune encephalomyelitis. J Immunol 2009; in press.
52. Giraudon P, Vincent P, Vuaillat C, Verlaeten O, Cartier L, Marie-Cardine A et al. Semaphorin CD100 from activated T lymphocytes induces process extension collapse in oligodendrocytes and death of immature neural cells. J Immunol 2004; 172: 1246-1255.
53. Kumanogoh A, Shikina T, Suzuki K, Uematsu S, Yukawa K, Kashiwamura S et al. Nonredundant roles of Sema4A in the immune system: defective T cell priming and Th1/Th2 regulation in Sema4A-deficient mice. Immunity 2005; 22: 305-316.
54. Kuchroo VK, Umetsu DT, DeKruyff RH, Freeman GJ. The TIM gene family: emerging roles in immunity and disease. Nat Rev Immunol 2003; 3: 454-462.
55. Chakravarti S, Sabatos CA, Xiao S, Illes Z, Cha EK, Sobel RA et al. Tim-2 regulates T helper type 2 responses and autoimmunity. J Exp Med 2005; 202: 437-444.
56. Makino N, Toyofuku T, Takegahara N, Takamatsu H, Okuno T, Nakagawa Y et al. Involvement of Sema4A in the progression of experimental autoimmune myocarditis. FEBS Lett 2008; 582: 3935-3940.
57. Yoshida Y, Han B, Mendelsohn M, Jessell TM. PlexinA1 signaling directs the segregation of proprioceptive sensory axons in the developing spinal cord. Neuron 2006; 52: 775-788.
58. Watarai H, Sekine E, Inoue S, Nakagawa R, Kaisho T, Taniguchi M. PDC-TREM, a plasmacytoid dendritic cell-specific receptor, is responsible for augmented production of type I interferon. Proc Natl Acad Sci USA 2008; 105: 2993-2998.
59. Wong AW, Brickey WJ, Taxman DJ, van Deventer HW, Reed W, Gao JX et al. CIITAregulated plexin-A1 affects T-cell-dendritic cell interactions. Nat Immunol 2003; 4: 891-898.
60. Kaifu T, Nakahara J, Inui M, Mishima K, Momiyama T, KajiM et al. Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice. J Clin Invest 2003; 111: 323-332.
61. Bakker AB, Hoek RM, Cerwenka A, Blom B, Lucian L, McNeil T et al. DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. Immunity 2000; 13: 345-353.
62. Tomasello E, Desmoulins PO, Chemin K, Guia S, Cremer H, Ortaldo J et al. Combined natural killer cell and dendritic cell functional deficiency in KARAP/DAP12 loss-offunction mutant mice. Immunity 2000; 13: 355-364.
63. Yamada A, Kubo K, Takeshita T, Harashima N, Kawano K, Mine T et al. Molecular cloning of a glycosylphosphatidylinositol-anchored molecule CDw108. J Immunol 1999; 162: 4094-4100.
64. Kang HR, Lee CG, Homer RJ, Elias JA. Semaphorin 7A plays a critical role in TGFbeta1-induced pulmonary fibrosis. J Exp Med 2007; 204: 1083-1093.
65. Kolodkin AL, Levengood DV, Rowe EG, Tai YT, Giger RJ, Ginty DD. Neuropilin is a semaphorin III receptor. Cell 1997; 90: 753-762.
66. Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 1998; 92: 735-745.
67. Tordjman R, Lepelletier Y, Lemarchandel V, Cambot M, Gaulard P, Hermine O et al. A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response. Nat Immunol 2002; 3: 477-482.
68. Serini G, Maione F, Giraudo E, Bussolino F. Semaphorins and tumor angiogenesis. Angiogenesis 2009; 12: 187-193.
69. Bruder D, Probst-Kepper M, Westendorf AM, Geffers R, Beissert S, Loser K et al. Neuropilin-1: a surface marker of regulatory T cells. Eur J Immunol 2004; 34: 623-630.
70. Sarris M, Andersen KG, Randow F, Mayr L, Betz AG. Neuropilin-1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition. Immunity 2008; 28: 402-413.
71. Yamamoto M, Suzuki K, Okuno T, Ogata T, Takegahara N, Takamatsu H et al. Plexin-A4 negatively regulates T lymphocyte responses. Int Immunol 2008; 20: 413-420.
72. Catalano A, Caprari P, Moretti S, Faronato M, Tamagnone L, Procopio A. Semaphorin-3A is expressed by tumor cells and alters T-cell signal transduction and function. Blood 2006; 107: 3321-3329.
73. Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009; 9: 239-252.
74. Pellet-Many C, Frankel P, Jia H, Zachary I. Neuropilins: structure, function and role in disease. Biochem J 2008; 411: 211-226.
75. Guttmann-Raviv N, Kessler O, Shraga-Heled N, Lange T, Herzog Y, Neufeld G. The neuropilins and their role in tumorigenesis and tumor progression. Cancer Lett 2006; 231: 1-11. (Pubitemid 41779447)
76. Bielenberg DR, Pettaway CA, Takashima S, Klagsbrun M. Neuropilins in neoplasms: expression, regulation, and function. Exp Cell Res 2006; 312: 584-593.
77. Acevedo LM, Barillas S, Weis SM, Gothert JR, Cheresh DA. Semaphorin3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor. Blood 2008; 111: 2674-2680.
78. Guttmann-Raviv N, Shraga-Heled N, Varshavsky A, Guimaraes-Sternberg C, Kessler O, Neufeld G. Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis. J Biol Chem 2007; 282: 26294-26305.
79. Bielenberg DR, Shimizu A, Klagsbrun M. Semaphorin-induced cytoskeletal collapse and repulsion of endothelial cells. Methods Enzymol 2008; 443: 299-314.
80. Kessler O, Shraga-Heled N, Lange T, Gutmann-Raviv N, Sabo E, Baruch L et al. Semaphorin-3F is an inhibitor of tumor angiogenesis. Cancer Res 2004; 64: 1008-1015.
81. Takahama Y. Journey through the thymus: stromal guides for T-cell development and selection. Nat Rev Immunol 2006; 6: 127-135.
82. Choi YI, Duke-Cohan JS, Ahmed WB, Handley MA, Mann F, Epstein JA et al. PlexinD1 glycoprotein controls migration of positively selected thymocytes into the medulla. Immunity 2008; 29: 888-898.
83. Alfaro D, Garcia-Ceca JJ, Cejalvo T, Jimenez E, Jenkinson EJ, Anderson G et al. EphrinB1-EphB signaling regulates thymocyte-epithelium interactions involved in functional T cell development. Eur J Immunol 2007; 37: 2596-2605.
84. Munoz JJ, Alfaro D, Garcia-Ceca J, Alonso CL, Jimenez E, Zapata A. Thymic alterations in EphA4-deficient mice. J Immunol 2006; 177: 804-813.
85. Ji JD, Park-Min KH, Ivashkiv LB. Expression and function of semaphorin 3A and its receptors in human monocyte-derived macrophages. Hum Immunol 2009; 70: 211-217.
86. Delaire S, Billard C, Tordjman R, Chedotal A, Elhabazi A, Bensussan A et al. Biological activity of soluble CD100. II. Soluble CD100, similarly to H-SemaIII, inhibits immune cell migration. J Immunol 2001; 166: 4348-4354.
87. Vincent P, Collette Y, Marignier R, Vuaillat C, Rogemond V, Davoust N et al. A role for the neuronal protein collapsin response mediator protein 2 in T lymphocyte polarization and migration. J Immunol 2005; 175: 7650-7660.
88. Chabbert-de Ponnat I, Marie-Cardine A, Pasterkamp RJ, Schiavon V, Tamagnone L, Thomasset N et al. Soluble CD100 functions on human monocytes and immature dendritic cells require plexin C1 and plexin B1, respectively. Int Immunol 2005; 17: 439-447.
89. Holmes S, Downs AM, Fosberry A, Hayes PD, Michalovich D, Murdoch P et al. Sema7A is a potent monocyte stimulator. Scand J Immunol 2002; 56: 270-275.
90. Walzer T, Galibert L, Comeau MR, de Smedt T. Plexin C1 engagement on mouse dendritic cells by viral semaphorin A39R induces actin cytoskeleton rearrangement and inhibits integrin-mediated adhesion and chemokine-induced migration. J Immunol 2005; 174: 51-59.
91. Lammermann T, Bader BL, Monkley SJ, Worbs T, Wedlich-Soldner R, Hirsch K et al. Rapid leukocyte migration by integrin-independent flowing and squeezing. Nature 2008; 453: 51-55.
92. Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 2007; 7: 678-689.